Olprinone, a Selective Phosphodiesterase III Inhibitor, Has Protective Effects in a Septic Rat Model after Partial Hepatectomy and Primary Rat Hepatocyte
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137189 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Masaya Kotsuka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kansai Medical University, Hirakata 573-1010, Japan. Hauptthemen laut MEDLINE: Hepatectomy, Hepatocytes, Pyridones, NF-kappa B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (C).
Abstract (Originalsprache)
Olprinone (OLP) is a selective inhibitor of phosphodiesterase III and is used clinically in patients with heart failure and those undergoing cardiac surgery; however, little is known about the effects of OLP on hepatoprotection. The purpose of this study aimed to determine whether OLP has protective effects in in vivo and in vitro rat models of endotoxin-induced liver injury after hepatectomy and to clarify the mechanisms of action of OLP. In the in vivo model, rats underwent 70% partial hepatectomy and lipopolysaccharide treatment (PH/LPS). OLP administration increased survival by 85.7% and decreased tumor necrosis factor-α, C-X-C motif chemokine ligand 1, and inducible nitric oxide synthase (iNOS) mRNA expression in the livers of rats treated with PH/LPS. OLP also suppressed nuclear translocation and/or DNA binding ability of nuclear factor kappa B (NF-κB). Pathological liver damage induced by PH/LPS was alleviated and neutrophil infiltration was reduced by OLP. Primary cultured rat hepatocytes treated with the pro-inflammatory cytokine interleukin-1β (IL-1β) were used as a model of in vitro liver injury. Co-treatment with OLP inhibited dose-dependently IL-1β-stimulated iNOS induction and NF-κB activation. Our results demonstrate that OLP may partially inhibit the induction of several inflammatory mediators through the suppression of NF-κB and thus prevent liver injury induced by endotoxin after liver resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Kansai Medical University, Hirakata 573-1010, Japan.
- Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu 525-8577, Japan.
- Department of Innovative Food Sciences, School of Food Sciences and Nutrition, Mukogawa Women's University, 6-46 Ikebiraki-cho, Nishinomiya 663-8558, Japan.
ORCID-Profile: Mikio Nishizawa, Katsuhiko Yoshizawa, Richi Nakatake
Förderung
- Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (C)
Zitieren
APA
Kotsuka, M., Okuyama, T., Hashimoto, Y., Kitade, H., Nishizawa, M., Yoshizawa, K., & Nakatake, R. (2024). Olprinone, a Selective Phosphodiesterase III Inhibitor, Has Protective Effects in a Septic Rat Model after Partial Hepatectomy and Primary Rat Hepatocyte. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137189
Vancouver
Kotsuka M, Okuyama T, Hashimoto Y, Kitade H, Nishizawa M, Yoshizawa K, et al. Olprinone, a Selective Phosphodiesterase III Inhibitor, Has Protective Effects in a Septic Rat Model after Partial Hepatectomy and Primary Rat Hepatocyte. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137189
BibTeX
@article{Kotsuka2024,
author = {Kotsuka, Masaya and Okuyama, Tetsuya and Hashimoto, Yuki and Kitade, Hiroaki and Nishizawa, Mikio and Yoshizawa, Katsuhiko and Nakatake, Richi},
title = {Olprinone, a Selective Phosphodiesterase III Inhibitor, Has Protective Effects in a Septic Rat Model after Partial Hepatectomy and Primary Rat Hepatocyte},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137189}
}
EUVIMED